|
US2015298120A1
|
|
Diagnostic cartridges having flexible seals
|
|
AU2010202492A1
|
|
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
|
US2011028703A1
|
|
Method and apparatus for suspending magnetic microparticles
|
|
US2010304360A1
|
|
Gold nanoparticle hpv genotyping system and assay
|
|
US2011014632A1
|
|
Assays for clinical assessments of rheumatoid arthritis
|
|
US2010144055A1
|
|
Assays For Clinical Assessments of Disease-Associated Autoantibodies
|
|
WO2010042126A1
|
|
Methods and assays to assess cardiac risk and ischemia
|
|
US2009233312A1
|
|
Methods and assays to assess cardiac risk and ischemia
|
|
WO2008105824A2
|
|
Direct detection of ligand-antiligand interactions by nanoscale switching
|
|
AU2007202887A1
|
|
Hybridization device and method
|
|
WO2007133704A2
|
|
A non-nucleic acid based biobarcode assay for detection of biological materials
|
|
US2010035243A1
|
|
Ultra-sensitive detection of analytes
|
|
AU2006209373A1
|
|
Nanoparticle imaging system and method
|
|
US2009111094A1
|
|
Methods for preparing hybrid substrates comprising DNA and antibodies and uses thereof
|
|
US2008020380A1
|
|
Method of denaturing and fragmenting DNA or RNA using ultrasound
|
|
US2011008907A1
|
|
System using self-contained processing module for detecting nucleic acids
|
|
US2007154903A1
|
|
Selective isolation and concentration of nucleic acids from complex samples
|
|
WO2006125124A2
|
|
Substrate functionalization method for high sensitivity applications
|
|
WO2006125050A2
|
|
Biobarcode assays for ultra high sensitive detection
|
|
AU2006200274A1
|
|
Nanoparticles Having Oligonucleotides Attached thereto and uses therefor
|
